Journal of Hematology & Oncology

official impact factor 2.93
Search for
Advanced search
Journal of Hematology & Oncology
Tools
Share this article
Open Access Email this article to a friend

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

Azra Raza*, Naomi Galili, Natalie Callander, Leonel Ochoa, Lawrence Piro, Peter Emanuel, Stephanie Williams, Howard Burris, Stefan Faderl, Zeev Estrov, Peter Curtin, Richard A Larson, James G Keck, Marsha Jones, Lisa Meng and Gail L Brown

Journal of Hematology & Oncology 2009, 2:20 doi:10.1186/1756-8722-2-20

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.